Douglas Quinton Larson - 04 Nov 2025 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Role
Chief Financial Officer
Signature
/s/ Douglas Quinton Larson
Issuer symbol
XAIR
Transactions as of
04 Nov 2025
Net transactions value
$0
Form type
4
Filing time
06 Nov 2025, 21:50:15 UTC
Previous filing
28 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Larson Douglas Quinton Chief Financial Officer C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY /s/ Douglas Quinton Larson 06 Nov 2025 0001880132

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XAIR Stock Options (Right to buy) Disposed to Issuer -15,000 -100% 0 04 Nov 2025 Common Stock 15,000 $10.80 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Award +15,000 15,000 04 Nov 2025 Common Stock 15,000 $1.95 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Disposed to Issuer -6,000 -100% 0 04 Nov 2025 Common Stock 6,000 $10.80 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Award +6,000 6,000 04 Nov 2025 Common Stock 6,000 $1.95 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Disposed to Issuer -1,000 -100% 0 04 Nov 2025 Common Stock 1,000 $10.80 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Award +1,000 1,000 04 Nov 2025 Common Stock 1,000 $1.95 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Disposed to Issuer -3,750 -100% 0 04 Nov 2025 Common Stock 3,750 $10.80 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Award +3,750 3,750 04 Nov 2025 Common Stock 3,750 $1.95 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Disposed to Issuer -17,500 -100% 0 04 Nov 2025 Common Stock 17,500 $5.89 Direct F1, F2
transaction XAIR Stock Options (Right to buy) Award +17,500 +58% 47,500 04 Nov 2025 Common Stock 17,500 $1.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged.
F2 This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.